While telehealth has been around for decades, the rapid evolution of technology and infrastructure over the past several years has created a new and exponentially growing field of digital health by merging telehealth with mobile applications (mHealth) and wearable technology. The advent of telehealth began more than 40 years ago with demonstrations of hospitals extending care to patients in remote areas. Telehealth use has spread rapidly and is now becoming integrated into the operations of clinics, hospitals, specialty departments, home health agencies, and patients' homes and workplaces. The National Conference of State Legislators (NCSL) indicates that use of telehealth services will increase from 250 000 patients in 2013 to 3.2 million by 2018, and more than 200 telehealth-related bills were introduced in 42 states in 2015.
1
Patients are gravitating toward mHealth solutions, feeling empowered by their newfound ability to manage their health, with easy access to medical information and advice in a convenient, timely, and cost-effective manner. Studies have shown that patients using digital health technologies are more engaged and informed about their health. [2] [3] [4] [5] These patients display greater motivation and capability to improve their health, and feel better equipped to have intelligent discussions with health care providers. 3, 4 Although a multitude of technological products are available, the health care industry has to determine how to shrink the gap between technological advancement and current health care reality.
Digital health is challenging the health care industry, an industry that historically has been slow to adopt new technology and is encumbered by significant regulatory barriers. 3, [6] [7] Although the pharmacy profession has not historically been early adapters of technology, patients trust and frequently interact with pharmacists, making pharmacists an excellent patient resource in this era of technological advancement. The purpose of this article is to generate awareness of the many facets of digital health, furthermore empowering pharmacists to become leaders of digital health solutions within and beyond their practice settings.
Digital health is an extension of telehealth, incorporating mHealth and wearable technology into patient care delivery. The terms telemedicine and telehealth are often used interchangeably, though telehealth is considered a broader definition of remote health care that does not always involve services provided by a clinical care team member. Telehealth includes a growing variety of applications and services using 2-way video, email, smartphones, wireless tools, and other forms of technology. 8 There are several examples of telehealth services outside the traditional office visit: These telehealth services focus on bringing care to patients in a way that fits their lifestyle. Not only does this improve patient satisfaction and access to care, but it also improves the quality and cost of care-all part of the Institute for Health Care Improvement's (IHI) Triple Aim to improve health care delivery and outcomes. Increased mobile device use has been paralleled by a proliferation in mHealth applications or "apps." 9 Health care professionals and patients alike have access to vast amounts of medical information through mHealth. One study revealed that 32% of US consumers have at least 1 health-related application on their mobile device. 10 According to the Food and Drug Administration (FDA), 50% of the 3.4 billion smartphone and tablet users will have a mHealth app by 2018. Consumers can optimize their personal health management using mHealth. Apps can improve medication adherence by reminding patients to take their medication. 10 Some apps track physical activity and patient nutrition habits, including steps walked and calories consumed and burned. 11 These logs may be reviewed by a health care professional to assist in managing a patient's health. mHealth can also be used to track or gather information on symptoms, guiding the patient to home care options or a visit with their health care provider. Health care professionals can utilize mobile apps in any setting to enhance the delivery of patient care.
The CCS Insight Global Wearables Forecast released in early 2016 predicts that the number of wearable health care devices will quadruple by year 2020, and patients will use device data to help make health care decisions. 12 Wearable technology is everywhere: A watch provides a glimpse into how well people sleep at night, and bracelets and exercise companions cause people to make extra movements to outperform their peers. Glasses with retina recognition provide insight into a patient's Parkinson disease symptoms. Digital scales upload daily weights to determine and monitor appropriate diuretic doses. Even more advanced technologies are being studied, such as using perspiration to run basic metabolic panels.
These devices are making small changes in patients' lives and have been linked to life saving efforts. In an article from USA Today, a 42-year-old man was rushed to an emergency room in New Jersey immediately following a seizure. 13 Doctors utilized data from the patient's personal fitness device to understand patterns in his heart rate and learn more about the man's unusual heart rhythm, which occurred a couple hours before his seizure. Using these data, doctors were able to pinpoint the exact time his heart rate spiked, and could even ascertain what time the patient had taken his heart rate controlling medication from noting a decrease in heart rate.
Wearable technology is already a part of most people's daily lives. These devices provide timely information outside the traditional office visit, allowing providers to discover trends and make better decisions. The possibilities are fascinating. Pharmacists must adapt quickly, incorporating wearable technology to aid decisions and help guide patient interactions, especially when patients are not physically present.
Mobile health applications and wearable technology have gained widespread adoption with the hope of decreasing chronic disease risk and prevalence; however, chronic diseases remain the leading cause of death and disability in the United States. Patients with 1 or more chronic diseases accounted for 86% of all health care spending in 2010; therefore, chronic disease-targeted applications have potential to significantly change health outcomes and how patient care is delivered. 14 Numerous apps now exist for diabetic patients to simplify carbohydrate counting, healthy cooking, and logging and analyzing blood glucose data. Technology will have the greatest impact on chronic conditions when monitors (glucometers, blood pressure monitors, etc) transmit clinical information to applications or directly to the individual's electronic medical record (EMR). This integration has already begun with the advent of wireless glucometers that transmit blood glucose levels to an insulin pump and are able to assist with bolus dosing. 15 Pharmacists and other clinicians will be better equipped to assist patients in reaching their goals with this real-time data.
Technology for chronic obstructive pulmonary disease (COPD) is also becoming more readily available. Sensors can be placed on inhalers to wirelessly track inhaler use over time, which can later undergo analysis by a health care provider. Applications are available to help patients stop smoking, remind patients to take medications, or comply with pulmonary rehabilitation exercises. 16 Other applications analyze self-reported patient symptoms and peak expiratory flow measurements to triage patients needing early intervention, decreasing time to intervention and reducing hospital readmissions. 17 Hospitals looking to decrease congestive heart failure (CHF) readmission rates are developing and testing software to educate patients via instructional videos, individual care plans, and medication education. This type of application also helps monitor patients, transmitting data back to health care providers regarding vital signs, medication adverse effects, and other health care concerns. This application contributed to the decrease in CHF readmissions by 53% at one hospital. 18 While the purpose of this article is to encourage pharmacists to lead innovative digital health solutions and advance practice, the authors feel they would be remiss in not acknowledging some of the difficulties of implementing digital health services that are outside normal workflow changes required within their own organization. This section is intended to generate awareness and challenge our pharmacy profession to address some of the larger scale issues that exist which cannot be solved by a single organization.
Currently, there is a lack of well-written legislation to recognize, define, or establish reimbursement for telehealth services. Twenty-nine states and the District of Columbia have laws requiring health insurers to cover telehealth visits; 8 of these states enacted new laws in 2015 alone. The NCSL estimates that 32 states will have laws in effect by 2017. 19 Increasingly, payers are reimbursing providers and health systems for telehealth services as they view them as more cost-effective than higher cost emergency department, urgent care, and office visits. Medicaid provides some level of coverage in most states (live video conferencing being most common), but the type of services and reimbursement amount still varies significantly. Medicare has lagged behind and only reimburses for rural telehealth services at this time. In 2015, Medicare paid only $17.6 million in telemedicine services out of the total $634 billion cost of the overall Medicare program. 19 In addition, there is some concern of using mobile technology for transmitting patient information in accordance with the Health Insurance Portability and Accountability Act (HIPAA).
Another barrier to adopting digital health into clinical practice is the lack of regulation regarding mHealth applications and devices. The FDA has determined it will only regulate applications that transform a mobile platform into a regulated medical device by using attachments, display screens, or sensors. 20 Applications that could cause patient harm if they were to malfunction will also be monitored by the government. 20 There is serious concern regarding the safety of these applications when used in real-world scenarios. A study reviewing available insulin dose calculator applications discovered that a number carry risk of providing incorrect dose recommendations based on patient parameters. 21 There remains a lack of consistent and robust outcomes data for mHealth applications and wearable technologies. The rate of application and device proliferation does not align with the time required to complete the typical health care research and publication process. By the time articles are published, it is possible that the application or device could be outdated or no longer available. In addition, most studies are small with results that are either inconclusive or contradictory to other studies. However, if properly designed, wearable technologies and mHealth applications can capture outcomes and other data to support evaluation of the technology, as well as identify opportunities for quality improvement. Until more rigorous data are published regarding clinical outcomes, digital health solutions may be viewed with skepticism and acceptance into practice may be prolonged.
With many digital health solutions focused on wellness, chronic disease state management, medication adherence, and the use of evidence-based decision making, pharmacists are uniquely positioned to help drive the digital health wave into the future. By first becoming familiar with digital health technologies and options, pharmacists can redefine the roles they play on health care teams in all practice settings. Due to pharmacist accessibility, patients will seek out their local pharmacist for technology and data synchronization issues with devices, technology, and software. We need to be prepared to not only answer patients' questions but also play an integral part in how patients incorporate digital health solutions into their health management.
One area where pharmacists can play a key role is related to mediation nonadherence which is estimated to add $300 billion in health care cost to the United States annually. 22 Pharmacists may assist patients in selecting and setting up medication adherence apps during an outpatient visit, inside a retail pharmacy, or in the acute care setting prior to discharge. On an ongoing basis, pharmacists can monitor patient adherence via apps and wearable devices. Advances in ambulatory medication dispensing devices can provide reminders to patients and transfer real-time data and warnings to caregivers. Apps that provide automatic dose change assessments can be pharmacist-monitored to ensure accurate recommendations are being provided.
Pharmacists can also incorporate digitally received patient clinical data into how they manage patients with chronic diseases-vital signs, drug levels, lab or point-ofcare test results, symptom questionnaires, and so on. In the not so distant future, pharmacists will be able to receive clinical data from a patient's mHealth app or wearable device. These data could first run through an automated algorithm to triage the clinical data results. If the results are within normal limits, the program would automatically notify the patient and remind them when to upload their data again. If the results are abnormal, the results would be forwarded for a pharmacist to review based on the urgency for follow-up (eg, immediate, within 24 hours, within 3-5 days). Based on when follow-up is needed, the patients can use their scheduling app to select a convenient time to talk with the pharmacist. When it is time for the patient's appointment, the pharmacist would video conference the patient, adding other caregivers by video or chat if needed. Upon visit completion, the video conference would be saved to the patient's portal for later review. In addition, it would be forwarded to the patient's primary care provider to keep them informed of the pharmacist-patient discussion and enhance the overall comprehensive multidisciplinary care of the patient.
Identifying and selecting mHealth apps for patients is another digital health service pharmacists can provide. The number of mHealth apps continues to increase at an extraordinary rate. Based on the IMS Institute for Healthcare Informatics, there were more than 165 000 apps available for download as of September 2015. Roughly 10% of these apps are able to connect to a device or sensor to provide biofeedback data, and almost a quarter focus on disease management. 23 However, only 36 apps account for nearly half of the total downloads, and 40% of apps have less than 5000 downloads. 23 Given the sheer amount of mHealth on the market, patients can easily download apps that give inappropriate or inaccurate information. To rectify this issue, several platforms have been developed to help providers prescribe mHealth apps. 23 IMS Health AppScript is one example. It allows providers to "prescribe health applications, devices, and digital content directly to patients' phones." 21 As there are currently no legal restrictions placed on the prescription of mHealth apps, pharmacists can also prescribe apps. Pharmacists are especially equipped to prescribe apps focused on medication adherence and chronic disease state management.
To appropriately prescribe mHealth apps, pharmacists must become familiar with apps specific to medication use, understanding which apps have attained quality and content approval from a governing body or reliable external organization. Similarly, medication-related apps that are being recommended by pharmacists within a health system should undergo a formal review process by both the informatics department and Pharmacy and Therapeutics Committee. Pharmacists should be integrated into each step of this mHealth app validation and approval process.
Pharmacists need to become involved with the development, testing, and early adoption of digital health solutions within their organizations. Early pharmacist involvement in the development of these solutions will ensure that designs are patient-friendly, safe, and accurate. When pharmacists are intimately involved in the development process, they will be more engaged in prescribing mHealth. This will promote pharmacist leverage of digital health technology, increasing their geographical reach beyond the practice setting where they are physically located.
Last, the pharmacy profession needs to advocate for legislative changes supporting the growth and safety of digital health solutions. Legislation defining telehealth is critical at both the federal and state levels to establish standards of care, supporting reimbursement for services provided. Regulation of mHealth and wearable devices is also required to ensure safe and accurate data are collected so that appropriate clinical decisions can be made using these data. In addition, we must guarantee that recommendations and references are accurate as well as current. Quality assurance measurement and reporting must exist to identify quality and safety issues.
The incorporation of mHealth and wearable technology into telehealth strategies will allow pharmacists to remain the most accessible health care provider, while having a positive impact on medication use. Based on the current state of digital health solutions and the opportunity for pharmacists to play a vital role, the authors challenge pharmacists to 1. Become familiar with medication-related applications (mHealth) and other technologies to help patients, in addition to providers, effectively select, use, and troubleshoot digital health services; 2. Engage with patients and providers to deliver care outside the traditional office visit; 3. Monitor patients through mHealth and wearable devices to assess medication adherence as well as adjust medications accordingly; 4. Prescribe mHealth apps to patients to help them better manage their health; 5. Work with technology programmers to design userfriendly applications to optimize medication use in all practice settings, while capturing quality data and reports to be used for device improvement and value measures; 6. Be legislative advocates to support recognition of telehealth and reimbursement as well as appropriate mHealth and device regulation; and finally, 7. Ask each patient about the digital health technologies they use to augment their care. If you are not familiar with the technology, take time to learn about it.
